Search
cbdMD Inc
YCBDAdd to Watchlist
0.685USD
+0.000+0.03%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
7.19MMarket Cap
0.02P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.03%
5 Days
-1.45%
1 Month
-8.67%
6 Months
-40.95%
Year to Date
-49.26%
1 Year
-20.35%
Key Figures
0.680Open
0.685High
72.42KVolume
0.02P/E TTM
LossP/E Dynamic
--Dividend TTM
0.69%Turnover Ratio
0.680Prev. Close
0.670Low
33.20KTurnover
LossP/E Static
0.77P/B
0.00%Div Yield TTM
-22.91%ROA
2.56052wk High
0.76Volume Ratio
-7.70MNet Profit
10.50MShares
28.1293EPS TTM
2.15Beta
-62.55%ROE
0.47052wk Low
2.21%Amplitude
53.29%Gross Margin
7.19MMarket Cap
-1.07Reward/Risk
8.73%Risk Rate
TradingKey Stock Score of cbdMD Inc
Currency: USD Updated: 2026-07-02Key Insights
cbdMD Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 105 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.00.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
cbdMD Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
cbdMD Inc Highlights
StrengthsRisks
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Growing
The company is in a growing phase, with the latest annual income totaling USD 19.19M.
Overvalued
The company’s latest PE is 0.02, at a high 3-year percentile range.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.000
Target Price
+194.16%
Upside Space
cbdMD Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
cbdMD Inc Info
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Ticker SymbolYCBD
CompanycbdMD Inc
CEOKennedy (T. Ronan)
Websitehttps://www.cbdmd.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of cbdMD Inc (YCBD)?
The current price of cbdMD Inc (YCBD) is 0.69.
What is the symbol of cbdMD Inc?
The ticker symbol of cbdMD Inc is YCBD.
What is the 52-week high of cbdMD Inc?
The 52-week high of cbdMD Inc is 2.56.
What is the 52-week low of cbdMD Inc?
The 52-week low of cbdMD Inc is 0.47.
What is the market capitalization of cbdMD Inc?
The market capitalization of cbdMD Inc is 7.19M.
Is cbdMD Inc (YCBD) currently rated as Buy, Hold, or Sell?
According to analysts, cbdMD Inc (YCBD) has an overall rating of Buy, with a price target of 2.00.
What is the Earnings Per Share (EPS TTM) of cbdMD Inc (YCBD)?
The Earnings Per Share (EPS TTM) of cbdMD Inc (YCBD) is -1.09.